UMC Utrecht study uncovers 29 novel antibodies against Klebsiella pneumoniae

Research at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections.

Abivax announces the release of its 2023 half-year financial report – Biotech Investments

EQS-News: ABIVAX / Key word(s): Half Year Report Abivax announces the release of its 2023 half-year financial report 29.09.2023 / 18:00 CET/CEST The issuer is solely

September 30, 2023

Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024 – Biotech Investments

EQS-News: M1 Kliniken AG / Key word(s): Miscellaneous M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in

February 17, 2024

Flu, Covid vaccination rates decline, as U.S. health officials make new push for inoculations

Vaccination rates against flu and Covid-19 have declined since earlier in the pandemic and a new survey suggests significant portions of the U.S. population intend

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.